Southern Asia: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Southern Asia

The South Asian market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose rapidly to $X in 2023, picking up by X% against the previous year. The total consumption indicated strong growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. The level of consumption peaked at $X in 2021; however, from 2022 to 2023, consumption stood at a somewhat lower figure.

Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Southern Asia

In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded modestly to $X in 2023 estimated in export price. The total production indicated notable growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth was the most pronounced in 2019 when the production volume increased by X% against the previous year. Over the period under review, production of attained the peak level at $X in 2021; however, from 2022 to 2023, production remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Exports in Southern Asia

In 2023, shipments abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second consecutive year after two years of growth. Total exports indicated noticeable growth from 2012 to 2023: its volume increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports decreased by X% against 2021 indices. The growth pace was the most rapid in 2021 with an increase of X%. As a result, the exports reached the peak of X tons. From 2022 to 2023, the growth of the exports of remained at a somewhat lower figure.

In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses reduced to $X in 2023. Over the period under review, exports recorded a noticeable curtailment. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. Over the period under review, the exports of hit record highs at $X in 2012; however, from 2013 to 2023, the exports remained at a lower figure.

Exports by Country

India dominates uses structure, reaching X tons, which was near X% of total exports in 2023. It was distantly followed by Nepal (X tons), creating a X% share of total exports.

From 2012 to 2023, average annual rates of growth with regard to non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exports from India stood at X%. At the same time, Nepal (X%) displayed positive paces of growth. Moreover, Nepal emerged as the fastest-growing exporter exported in Southern Asia, with a CAGR of X% from 2012-2023. While the share of India (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) remains the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses supplier in Southern Asia, comprising X% of total exports. The second position in the ranking was held by Nepal ($X), with a X% share of total exports.

In India, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

The export price in Southern Asia stood at $X per ton in 2023, growing by X% against the previous year. Over the period under review, the export price, however, showed a pronounced downturn. The pace of growth was the most pronounced in 2018 when the export price increased by X%. Over the period under review, the export prices attained the maximum at $X per ton in 2012; however, from 2013 to 2023, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was India ($X per ton), while Nepal amounted to $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Nepal (X%).

Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Imports in Southern Asia

In 2023, overseas purchases of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after three years of decline. Over the period under review, imports enjoyed a prominent increase. The pace of growth was the most pronounced in 2013 with an increase of X% against the previous year. The volume of import peaked at X tons in 2017; however, from 2018 to 2023, imports failed to regain momentum.

In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses reached $X in 2023. In general, imports showed a resilient increase. The most prominent rate of growth was recorded in 2013 with an increase of X%. The level of import peaked at $X in 2016; however, from 2017 to 2023, imports stood at a somewhat lower figure.

Imports by Country

In 2023, India (X tons) represented the major importer of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses, committing X% of total imports. It was distantly followed by Nepal (X tons), Bangladesh (X tons) and Sri Lanka (X tons), together mixing up a X% share of total imports. Pakistan (X tons) held a little share of total imports.

India was also the fastest-growing in terms of the non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses imports, with a CAGR of X% from 2012 to 2023. At the same time, Bangladesh (X%), Sri Lanka (X%), Nepal (X%) and Pakistan (X%) displayed positive paces of growth. From 2012 to 2023, the share of India increased by X percentage points. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) constitutes the largest market for imported non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Southern Asia, comprising X% of total imports. The second position in the ranking was held by Nepal ($X), with a X% share of total imports. It was followed by Bangladesh, with an X% share.

From 2012 to 2023, the average annual growth rate of value in India amounted to X%. In the other countries, the average annual rates were as follows: Nepal (X% per year) and Bangladesh (X% per year).

Import Prices by Country

The import price in Southern Asia stood at $X per ton in 2023, increasing by X% against the previous year. Over the period under review, the import price, however, showed a perceptible decline. The growth pace was the most rapid in 2014 when the import price increased by X%. Over the period under review, import prices attained the maximum at $X per ton in 2012; however, from 2013 to 2023, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Pakistan ($X per ton), while Sri Lanka ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Nepal (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform